Found: 39
Select item for more details and to access through your institution.
SARS‐CoV‐2 antibody levels and long COVID occurrence in blood donors.
- Published in:
- Transfusion, 2024, v. 64, n. 9, p. 1719, doi. 10.1111/trf.17952
- By:
- Publication type:
- Article
Interpreting HIV diagnostic histories into infection time estimates: analytical framework and online tool.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.
- Published in:
- JMIR Public Health & Surveillance, 2022, v. 8, n. 3, p. 1, doi. 10.2196/34410
- By:
- Publication type:
- Article
Clinical Protection During the First Omicron Wave in Unvaccinated, Convalescent US Adults.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 2, p. 212, doi. 10.1001/jama.2022.10332
- By:
- Publication type:
- Article
Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 7, p. 1075, doi. 10.3390/v16071075
- By:
- Publication type:
- Article
Blood Center Testing Allows the Detection and Rapid Treatment of Acute and Recent HIV Infection.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2326, doi. 10.3390/v14112326
- By:
- Publication type:
- Article
The Impact of Early Antiretroviral Treatment (ART) for HIV on the Sensitivity of the Latest Generation of Blood Screening and Point of Care Assays.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/v14071426
- By:
- Publication type:
- Article
Standardized evaluation of Zika nucleic acid tests used in clinical settings and blood screening.
- Published in:
- PLoS Neglected Tropical Diseases, 2023, v. 16, n. 3, p. 1, doi. 10.1371/journal.pntd.0011157
- By:
- Publication type:
- Article
Quantitative interpretation of Sedia LAg Assay test results after HIV diagnosis.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271763
- By:
- Publication type:
- Article
Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0267902
- By:
- Publication type:
- Article
The impact of non‐disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 6, p. 581, doi. 10.1111/vox.13627
- By:
- Publication type:
- Article
The evolution and interpretation of seroprevalence of SARS‐CoV‐2 antibodies among South African blood donors from the Beta to Omicron variant‐driven waves.
- Published in:
- Vox Sanguinis, 2024, v. 119, n. 3, p. 242, doi. 10.1111/vox.13571
- By:
- Publication type:
- Article
10‐year analysis of human immunodeficiency virus incidence in first‐time and repeat donors in Brazil.
- Published in:
- Vox Sanguinis, 2021, v. 116, n. 2, p. 207, doi. 10.1111/vox.13002
- By:
- Publication type:
- Article
HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods.
- Published in:
- Vox Sanguinis, 2021, v. 116, n. 1, p. 71, doi. 10.1111/vox.12987
- By:
- Publication type:
- Article
Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes.
- Published in:
- Transfusion, 2019, v. 59, n. 1, p. 267, doi. 10.1111/trf.14959
- By:
- Publication type:
- Article
Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07094-y
- By:
- Publication type:
- Article
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222290
- By:
- Publication type:
- Article
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
- Published in:
- PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0220345
- By:
- Publication type:
- Article
Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S254, doi. 10.1093/cid/ciac470
- By:
- Publication type:
- Article
Surveillance for Zika, Chikungunya, and Dengue Virus Incidence and RNAemia in Blood Donors at 4 Brazilian Blood Centers During 2016–2019.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 5, p. 696, doi. 10.1093/infdis/jiac173
- By:
- Publication type:
- Article
COVID-19 vaccine effectiveness against SARS-CoV-2 infection in the United States prior to the Delta and Omicron-associated surges: a retrospective cohort study of repeat blood donors.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 9, p. 1556, doi. 10.1093/infdis/jiac318
- By:
- Publication type:
- Article
Facilitating Next‐Generation Pre‐Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design Project.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 1, p. 29, doi. 10.1002/cpt.2830
- By:
- Publication type:
- Article
HIV Subtypes and Drug-resistance-associated Mutations in US Blood Donors, 2015–2020.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae343
- By:
- Publication type:
- Article
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status -- United States, April 2021-September 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 22, p. 601, doi. 10.15585/mmwr.mm7222a3
- By:
- Publication type:
- Article
Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 8, p. 1621, doi. 10.3201/eid3008.240659
- By:
- Publication type:
- Article
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.
- Published in:
- 2022
- By:
- Publication type:
- journal article
How do we...form and coordinate a national serosurvey of SARS‐CoV‐2 within the blood collection industry?
- Published in:
- Transfusion, 2022, v. 62, n. 7, p. 1321, doi. 10.1111/trf.16943
- By:
- Publication type:
- Article
SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance.
- Published in:
- Transfusion, 2021, v. 61, n. 9, p. 2677, doi. 10.1111/trf.16555
- By:
- Publication type:
- Article
Minipool testing for SARS‐CoV‐2 RNA in United States blood donors.
- Published in:
- Transfusion, 2021, v. 61, n. 8, p. 2384, doi. 10.1111/trf.16511
- By:
- Publication type:
- Article
Factors driving availability of COVID‐19 convalescent plasma: Insights from a demand, production, and supply model.
- Published in:
- Transfusion, 2021, v. 61, n. 5, p. 1370, doi. 10.1111/trf.16317
- By:
- Publication type:
- Article
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Recently acquired infection among HIV‐seropositive donors in the US from 2010‐2018.
- Published in:
- Transfusion, 2020, v. 60, n. 10, p. 2340, doi. 10.1111/trf.16032
- By:
- Publication type:
- Article
A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors.
- Published in:
- Cell & Tissue Banking, 2023, v. 24, n. 3, p. 585, doi. 10.1007/s10561-022-10054-0
- By:
- Publication type:
- Article
Population-level HIV incidence estimates using a combination of synthetic cohort and recency biomarker approaches in KwaZulu-Natal, South Africa.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203638
- By:
- Publication type:
- Article
Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195575
- By:
- Publication type:
- Article
AIDS Conspiracy Beliefs and Unsafe Sex in Cape Town.
- Published in:
- AIDS & Behavior, 2012, v. 16, n. 3, p. 761, doi. 10.1007/s10461-011-9958-2
- By:
- Publication type:
- Article